These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12421263)

  • 21. Culture and antigen detection tests for streptococcal tonsillopharyngitis.
    Tocks JB
    Am Fam Physician; 1992 Dec; 46(6):1657-8; author reply 1658-9, 1662. PubMed ID: 1456192
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pharyngotonsillitis caused by Streptococcus pyogenes: clinical and epidemiological aspects and resistance phenotypes towards macrolides].
    Crotti D; D'Annibale ML; Ubaldi M; Fonzo G; Medori MC
    Infez Med; 2002 Dec; 10(4):213-9. PubMed ID: 12754427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Susceptibility of Streptococcus pyogenes isolates from pharyngeal exudates in Cordoba (Spain)].
    Gordillo RM; Lacasa MJ; Ibarra A; Rodríguez F; Casal M
    Rev Esp Quimioter; 2003 Mar; 16(1):58-60. PubMed ID: 12750758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences between macrolide-resistant and -susceptible Streptococcus pyogenes: importance of clonal properties in addition to antibiotic consumption.
    Silva-Costa C; Friães A; Ramirez M; Melo-Cristino J;
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5661-6. PubMed ID: 22908153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decline in macrolide resistance rates among Streptococcus pyogenes causing pharyngitis in children isolated in Italy.
    Gherardi G; Petrelli D; Di Luca MC; Pimentel de Araujo F; Bernaschi P; Repetto A; Bellesi J; Vitali LA
    Eur J Clin Microbiol Infect Dis; 2015 Sep; 34(9):1797-802. PubMed ID: 26024763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High prevalence of erythromycin resistance of Streptococcus pyogenes in Greek children.
    Syrogiannopoulos GA; Grivea IN; Fitoussi F; Doit C; Katopodis GD; Bingen E; Beratis NG
    Pediatr Infect Dis J; 2001 Sep; 20(9):863-8. PubMed ID: 11734765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cephalosporins are superior to penicillin for treatment of streptococcal tonsillopharyngitis: is the difference worth it?
    Pichichero ME
    Pediatr Infect Dis J; 1993 Apr; 12(4):268-74. PubMed ID: 8483619
    [No Abstract]   [Full Text] [Related]  

  • 28. Macrolide-resistant genes of Streptococcus pyogenes isolated from the upper respiratory tract by polymerase chain reaction.
    Billal DS; Hotomi M; Yamauchi K; Fujihara K; Tamura S; Kuki K; Sugita R; Endou M; Mukaigawa J; Yamanaka N
    J Infect Chemother; 2004 Apr; 10(2):115-20. PubMed ID: 15160306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Streptococcal-A tonsillopharyngitis: a 5-day course of cefuroxime axetil versus a 10-day course of penicillin V. results depending on the children's age.
    Scholz H
    Chemotherapy; 2004 Apr; 50(1):51-4. PubMed ID: 15084807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of macrolide resistance by ribosomal protein L4 mutation in Streptococcus pyogenes during miocamycin treatment of an eight-year-old Greek child with tonsillopharyngitis.
    Bozdogan B; Appelbaum PC; Ednie L; Grivea IN; Syrogiannopoulos GA
    Clin Microbiol Infect; 2003 Sep; 9(9):966-9. PubMed ID: 14616688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Erythromycin-resistant Streptococcus pyogenes].
    Lazarević G; Laban-Nestorović S; Jovanović M; Potkonjak B
    Srp Arh Celok Lek; 2004 Oct; 132 Suppl 1():42-4. PubMed ID: 15615464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Isolated susceptibility of Streptococcus pyogenes to 3 macrolides].
    Sakran W; Raz R; Colodner R; Keness Y
    Harefuah; 1997 Nov; 133(9):365-6, 414. PubMed ID: 9418339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Streptococcus pyogenes collected in Torino (northwest Italy) between 1983 and 1998: survey of macrolide resistance and trend of genotype by RAPD.
    Avanzini C; Bosio K; Volpe G; Dotti G; Savoia D
    Microb Drug Resist; 2000; 6(4):289-95. PubMed ID: 11272257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and phenotypic characterization of macrolide resistance in group A streptococci isolated from adults with pharyngo-tonsillitis in France.
    Weber P; Filipecki J; Bingen E; Fitoussi F; Goldfarb G; Chauvin JP; Reitz C; Portier H
    J Antimicrob Chemother; 2001 Aug; 48(2):291-4. PubMed ID: 11481304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrolide- and telithromycin-resistant Streptococcus pyogenes, Belgium, 1999-2003.
    Malhotra-Kumar S; Lammens C; Chapelle S; Wijdooghe M; Piessens J; Van Herck K; Goossens H
    Emerg Infect Dis; 2005 Jun; 11(6):939-42. PubMed ID: 15963292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resistance to erythromycin and telithromycin in Streptococcus pyogenes isolates obtained between 1999 and 2002 from Greek children with tonsillopharyngitis: phenotypic and genotypic analysis.
    Grivea IN; Al-Lahham A; Katopodis GD; Syrogiannopoulos GA; Reinert RR
    Antimicrob Agents Chemother; 2006 Jan; 50(1):256-61. PubMed ID: 16377695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antibiotic therapy against acute tonsillopharyngitis in children due to group A beta-hemolytic streptococci: comparison of clinical efficacy, the bactericidal effects, and effects on oral flora between cefditoren pivoxil for 5 days and amoxicillin for 10 days].
    Tsumura N; Nagai K; Hidaka H; Otsu Y; Tanaka Y; Ikezawa S; Honma S; Shindo S; Ubukata K
    Jpn J Antibiot; 2011 Jun; 64(3):179-90. PubMed ID: 21861309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Higher dosages of azithromycin are more effective in treatment of group A streptococcal tonsillopharyngitis.
    Casey JR; Pichichero ME
    Clin Infect Dis; 2005 Jun; 40(12):1748-55. PubMed ID: 15909262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Azithromycin versus cefaclor in the treatment of pediatric patients with acute group A beta-hemolytic streptococcal tonsillopharyngitis.
    Cremer J; Wallrauch C; Milatovic D; Braveny I
    Eur J Clin Microbiol Infect Dis; 1998 Apr; 17(4):235-9. PubMed ID: 9707305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of macrolide-resistance and comparative activity of telithromycin in streptococci in Austria, 1996-2002.
    Buxbaum A; Forsthuber S; Sauermann R; Gattringer R; Graninger W; Georgopoulos A;
    Int J Antimicrob Agents; 2004 Oct; 24(4):397-400. PubMed ID: 15380268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.